Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)

Journal of Medical Toxicology(2023)10.1007/s13181-023-00931-9Source: DataRank Database

COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics) is a research paper published in Journal of Medical Toxicology (2023). On theSindex it has a DataRank of 0.483. It has been cited 24 times.

N/A

0.483DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 4.00)OA: bronzeTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.483

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (6)

Alexander F. Barbuto,Sudeh Izadmehr ORCID,Marc Tarsillo,Eduardo Fleischer,Michele M. Burns

Live enrichment

PubMed:36862334 PMC:PMC9979891 OpenAlex:https://openalex.org/W4322758687

National Center for Advancing Translational Sciences

Grant: LRP

NCI NIH HHS

Grant: T32 CA078207

National Institutes of Health

Grant: 5T32CA078207-05

TRAINING PROGRAM IN CANCER BIOLOGY

FWCI

4.00

Citation Percentile

0.9%

Influential Citations

Citation Trend

2023

2024

2025

2026

bronzeLicense: Springer Nature TDM

journalhttps://link.springer.com/content/pdf/10.1007/s13181-023-00931-9.pdf

BRONZEhttps://link.springer.com/content/pdf/10.1007/s13181-023-00931-9.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s13181-023-00931-9.pdf

publisherhttps://link.springer.com/article/10.1007/s13181-023-00931-9/fulltext.html

journalhttps://doi.org/10.1007/s13181-023-00931-9

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and ThrombosisMedicine0303 health sciences03 medical and health sciencesFemaleHumansMaleAntibodies, MonoclonalCOVID-19COVID-19 SerotherapyImmunotherapyPandemicsSARS-CoV-2Vaccines

MeSH Terms

COVID-19SARS-CoV-2COVID-19 SerotherapyAntibodies, MonoclonalFemaleHumansImmunotherapyMaleVaccinesPandemics

Keywords

MedicineMonoclonal antibodyCoronavirus disease 2019 (COVID-19)Mechanism of actionVirologyMechanism (biology)ToxicityAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPharmacologyImmunologyInfectious disease (medical specialty)DiseaseInternal medicineBiologyOutbreakVaccinesMonoclonal antibodiesImmunotherapyCovid-19MaleSARS-CoV-2HumansAntibodies, MonoclonalFemaleReviewPandemicsCOVID-19 Serotherapy

Sustainable Development Goals

SDG 0: Good health and well-being

COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)

FAIR Checklist

DataRank Breakdown

Authors (6)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)